Lorlatinib shows unprecedented success in advanced NSCLC

from Medical News Podcast · host PeerDirect Publishing

Which drug keeps lung cancer from progressing for over 5 years? Find out about this and more in today's PeerDirect Medical News Podcast.

Episode metadata supplied by the publisher feed · Published Jun 11, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Lorlatinib shows unprecedented success in advanced NSCLC

0:00 4:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 4 minutes long.

This episode was published on June 11, 2024.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!